Job Objective :
The Cost Controller will play a key role in monitoring, analyzing, and managing the costs associated with plasma procurement and related operations. Working closely with, Plasma procurement, procurement, Center managers, warehouse keepers and finance teams, this role ensures accurate cost tracking, adherence to budgets, and identification of cost optimization opportunities across the production lifecycle.
Key responsibility
Monitor and control Plasma procurement costs across plasma processing facilities to ensure alignment with approved budgets.
Analyze variances between actual and standard costs and provide detailed reports to management.
Track raw material usage on daily basis and collaborate with procurement and inventory teams to track cost efficiency, especially for critical Material.
Ensure accurate cost allocation for batch processing, purification, filling, and packaging stages monthly.
Prepare the inventory physical count on a quarterly basis.
Assists in preparing (LRP).
Assist in annual budgeting and forecasting activities with a focus on production and operational cost drivers.
Maintain daily, weekly, and monthly cost dashboards to provide real-time visibility of key cost drivers across donor centers and plasma logistics operations.
Validate and reconcile plasma collection volumes, donor compensation payments, and logistics costs to ensure proper cost booking and cost per liter accuracy.
Coordinate closely with Center Managers to monitor labor efficiency, overtime trends, and productivity ratios that impact procurement cost.
Support finance in the month-end closing by preparing and/or reviewing accruals, cost adjustments, and reconciliation of procurement and production expenses.
Monitor vendor pricing, contract terms, and purchase order deviations to identify cost reduction or renegotiation opportunities.
Review and validate fixed asset utilization for plasma procurement equipment and ensure correct depreciation allocation.
Support audits related to cost control, inventory handling, and financial compliance.
Contribute to continuous improvement initiatives aimed at reducing Cost per Liter and optimizing spending across plasma procurement centers.
Academic experience required
Bachelors degree in Finance, Accounting, or a related field (experience in Pharmaceutical
industry preferred).
Preferred to have Professional certification such as (CMA, FMVA).
Professional Experience Required
3–5 years of experience in Cost Control, Finance, or Financial Analysis.
Experience with cost modeling.
Computing Skills
Strong knowledge of cost accounting principles and ERP systems (SAP).
Proficiency in Excel and data analysis tools.
Personal Skills
Integrity and Confidentiality: Maintains a high level of ethics and discretion when handling
sensitive cost and operational data.
Attention to Detail: critical in cost tracking and variance analysis, especially in regulated
environments like plasma procurement.
Analytical Thinking: Strong ability to interpret complex financial and operational data to support
informed decision-making.
Ability to work in a fast-paced, regulated environment with cross-functional teams.
Languages
Upper intermediate command in English.
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people.
This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region.
GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system.
We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future.
The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.
